Author:
Tinker Sarah C.,Szablewski Christine M.,Litvintseva Anastasia P.,Drenzek Cherie,Voccio Gary E.,Hunter Melissa A.,Briggs Stephen,Heida Debbie E.,Folster Jennifer,Shewmaker Patricia L.,Medrzycki Magdalena,Bowen Michael D.,Bohannon Caitlin,Bagarozzi Dennis,Petway Marla,Rota Paul A.,Kuhnert-Tallman Wendi,Thornburg Natalie,Prince-Guerra Jessica L.,Barrios Lisa C.,Tamin Azaibi,Harcourt Jennifer L.,Honein Margaret A., ,
Publisher
Centers for Disease Control and Prevention (CDC)
Subject
Infectious Diseases,Microbiology (medical),Epidemiology
Reference11 articles.
1. US Food and Drug Administration. BinaxNOW COVID-19 Ag Card emergency use authorization. 2020 [cited 2021 Jun 28]. https://www.fda.gov/media/147264/download
2. Centers for Medicare and Medicaid Services. Updated CLIA SARS-CoV-2 molecular and antigen point of care test enforcement discretion. 2020 [cited 2021 Jun 28]. https://www.cms.gov/files/document/clia-sars-cov-2-point-care-test-enforcement-discretion.pdf
3. Georgia Department of Public Health. Covid-19 daily status report, by county (Floyd County, November 16th). 2020 [cited 2021 Feb 28]. https://dph.georgia.gov/covid-19-daily-status-report
4. US Food and Drug Administration. BinaxNOW COVID-19 Ag Card—instructions for use. 2020 [cited 2021 Jun 28]. https://www.fda.gov/media/141570/download
5. US Food and Drug Administration. Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay emergency use authorization. 2020 [cited 2021 Jun 28]. https://www.fda.gov/media/139744/download